Douglas Michael  Garis net worth and biography

Douglas Garis Biography and Net Worth

CFO of Claritev
Doug is an accomplished finance executive with distinct global public markets expertise. He leads Multiplan’s finance and accounting team and specializes in FP&A, corporate strategy, capital deployment, and financial operations. Prior to joining the Company, Doug was the CFO of Oracle’s largest vertical industry – Oracle Health and Life Sciences following Oracle’s $28 billion acquisition of Cerner in 2022 (previously Head of FP&A at Cerner). He began his career at PwC and held multiple financial leadership roles at Masonite International Corporation. Doug holds an MBA in finance from The University of Tampa’s Skyes School of Business.

What is Douglas Michael Garis' net worth?

The estimated net worth of Douglas Michael Garis is at least $4.43 million as of August 6th, 2024. Mr. Garis owns 118,035 shares of Claritev stock worth more than $4,432,214 as of December 4th. This net worth evaluation does not reflect any other investments that Mr. Garis may own. Learn More about Douglas Michael Garis' net worth.

How do I contact Douglas Michael Garis?

The corporate mailing address for Mr. Garis and other Claritev executives is , , . Claritev can also be reached via phone at 1-800-677-1098 and via email at [email protected]. Learn More on Douglas Michael Garis' contact information.

Has Douglas Michael Garis been buying or selling shares of Claritev?

Douglas Michael Garis has not been actively trading shares of Claritev in the last ninety days. Most recently, on Tuesday, August 6th, Douglas Michael Garis bought 28,750 shares of Claritev stock. The stock was acquired at an average cost of $12.00 per share, with a total value of $345,000.00. Following the completion of the transaction, the chief financial officer now directly owns 118,035 shares of the company's stock, valued at $1,416,420. Learn More on Douglas Michael Garis' trading history.

Who are Claritev's active insiders?

Claritev's insider roster includes Glenn August (Director), Anthony Colaluca, Jr (Director), Travis Dalton (President, CEO), Paul Galant (Insider), Douglas Garis (CFO), James Head (CFO), Julie Klapstein (Director), Michael Klein (Director), and William Mintz (SVP, Corporate Affairs & Strategy). Learn More on Claritev's active insiders.

Are insiders buying or selling shares of Claritev?

During the last twelve months, Claritev insiders bought shares 5 times. They purchased a total of 17,347 shares worth more than $710,937.70. During the last twelve months, insiders at the sold shares 1 times. They sold a total of 1,500,000 shares worth more than $73,005,000.00. The most recent insider tranaction occured on November, 20th when CEO Travis Dalton bought 5,290 shares worth more than $249,846.70. Insiders at Claritev own 8.0% of the company. Learn More about insider trades at Claritev.

Information on this page was last updated on 11/20/2025.

Douglas Michael Garis Insider Trading History at Claritev

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/6/2024Buy28,750$12.00$345,000.00118,035View SEC Filing Icon  
See Full Table

Douglas Michael Garis Buying and Selling Activity at Claritev

This chart shows Douglas Michael Garis's buying and selling at Claritev by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Claritev Company Overview

Claritev logo
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
Read More

Today's Range

Now: $36.77
Low: $36.45
High: $40.51

50 Day Range

MA: $54.97
Low: $36.77
High: $71.36

2 Week Range

Now: $36.77
Low: $5.61
High: $74.07

Volume

199,937 shs

Average Volume

263,456 shs

Market Capitalization

$607.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.52